Schedule 13G ownership disclosure
MARINUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 56854Q101
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,368,811
- Percent of class
- 1.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-000490
- Form type
- SC 13G
- Filer
- Granite Point Capital Management, L.P.
- CIK
- CIK 1599562
- Filed
- Jan 27, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership